DXCM
$80.25-6.40%
as of close, Oct 21, 2026
☾ AH $80.25 -6.40%
DXCM SEC filings (2026)
CIK 1093557 · Surgical & Medical Instruments & Apparatus (SIC 3841) · incorporated in DE · fiscal year ends in December
2,601 filings on EDGAR since 2002 · 23 annual, 66 quarterly, 279 current · financial statements · earnings
Latest 10-K
Feb 12, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Jul 30, 2026
quarter to Jun 30, 2026
Latest 8-K
Sep 14, 2026
Dexcom Promotes Jereme Sylvain to Chief Operating Officer
Last earnings release
Jul 30, 2026
$0.70 vs $0.61 · ▲ 12.0%
Filings on file
2,601
since 2002, 1,945 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
October 2026
September 2026
- Sep 28Insider saleStern Sadie (EVP Chief People & Culture Off) sold 2,565 shares for $221K at $86.15 under a 10b5-1 plan
- Sep 15Insider saleAUGUSTINOS NICHOLAS (Director) sold 6,539 shares for $550K at $84.04 under a 10b5-1 plan
- Sep 15Insider saleBrown Michael Jon (EVP Chief Legal Compliance Off) sold 1,700 shares for $143K at $84.04 under a 10b5-1 plan
- Sep 14Insider saleAUGUSTINOS NICHOLAS (Director) sold 1,550 shares for $130K at $84.02 under a 10b5-1 plan
- Sep 148-K8-K · Dexcom Promotes Jereme Sylvain to Chief Operating OfficerDirectors or officers; compensation; Regulation FD disclosure
- Sep 10Insider saleSylvain Jereme M (EVP, Chief Financal Officer) sold 3,638 shares for $303K at $83.27 under a 10b5-1 plan
- Sep 108-K8-K · Dexcom Appoints Glenn Boehnlein to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
August 2026
- Aug 27Insider saleStern Sadie (EVP Chief People & Culture Off) sold 2,565 shares for $227K at $88.37 under a 10b5-1 plan
- Aug 20Insider saleSAYER KEVIN R (Executive Chair · Director) sold 26,756 shares for $2.4M at $89.71–$91.41 under a 10b5-1 plan
- Aug 14Insider saleBrown Michael Jon (EVP Chief Legal Compliance Off) sold 1,700 shares for $156K at $91.93 under a 10b5-1 plan
- Aug 12Insider saleHeller Bridgette P (Director) sold 1,012 shares for $89K at $88.29 under a 10b5-1 plan
- Aug 3Insider saleFOLETTA MARK G (Director) sold 2,000 shares for $171K at $85.32 under a 10b5-1 plan
July 2026
- Jul 31Insider saleFOLETTA MARK G (Director) sold 2,000 shares for $160K at $80.00 under a 10b5-1 plan
- Jul 30EarningsEarnings release — EPS $0.70 vs $0.61 est. (+14.8%); revenue $1.31B (+13% y/y) 12.0%
- Jul 30ReportQuarterly report, Q2 2026 — revenue $1.31B (+13% y/y), net income $249.1M, EPS $0.64
- Jul 20Insider saleSAYER KEVIN R (Executive Chair · Director) sold 26,756 shares for $2.0M at $76.32 under a 10b5-1 plan
- Jul 15Insider saleBrown Michael Jon (EVP Chief Legal Compliance Off) sold 1,700 shares for $127K at $74.42 under a 10b5-1 plan
- Jul 6Insider saleSAYER KEVIN R (Executive Chair · Director) sold 26,756 shares for $1.9M at $72.00 under a 10b5-1 plan
June 2026
- Jun 15Insider saleFOLETTA MARK G (Director) sold 4,000 shares for $297K at $74.10–$74.82 under a 10b5-1 plan
- Jun 15Insider saleBrown Michael Jon (EVP Chief Legal Compliance Off) sold 1,700 shares for $128K at $75.55 under a 10b5-1 plan
- Jun 4Insider saleColeman Jon (EVP, Chief Commercial Officer) sold 4,911 shares for $364K at $74.13 under a 10b5-1 plan
- Jun 3Insider saleColeman Jon (EVP, Chief Commercial Officer) sold 4,912 shares for $359K at $73.00 under a 10b5-1 plan
May 2026
- May 288-K8-K · Shareholder vote results
- May 21Insider saleSAYER KEVIN R (Executive Chair · Director) sold 26,759 shares for $1.9M at $72.00 under a 10b5-1 plan
- May 15Insider saleBrown Michael Jon (EVP, Chief Legal Officer) sold 1,700 shares for $102K at $59.91 under a 10b5-1 plan
- May 158-K8-K · Regulation FD disclosure; Other events
- May 12Insider saleHeller Bridgette P (Director) sold 1,012 shares for $61K at $60.01 under a 10b5-1 plan
April 2026
- Apr 30EarningsEarnings release — EPS $0.56 vs $0.47 est. (+19.1%); revenue $1.19B (+15% y/y) 3.0%
- Apr 30ReportQuarterly report, Q1 2026 — revenue $1.19B (+15% y/y), net income $199.5M, EPS $0.51
- Apr 15Insider saleBrown Michael Jon (EVP, Chief Legal Officer) sold 1,700 shares for $107K at $63.04 under a 10b5-1 plan
- Apr 15ProxyProxy · Annual report to shareholders
- Apr 15ProxyProxy · Additional proxy materials
- Apr 15ProxyProxy · Proxy statement
March 2026
February 2026
- Feb 268-K8-K · Dexcom Appoints Rick Osterloh to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
- Feb 12EarningsEarnings release — EPS $0.68 vs $0.65 est. (+4.6%); revenue $1.26B (+13% y/y) 7.6%
- Feb 12ReportAnnual report, FY2025 — revenue $4.66B (+16% y/y), net income $836.3M, EPS $2.09
- Feb 12Insider saleHeller Bridgette P (Director) sold 1,012 shares for $69K at $68.01 under a 10b5-1 plan
January 2026
- Jan 128-K8-K · Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 OutlookResults of operations
December 2025
- Dec 228-K8-K · Directors or officers; compensation
October 2025
- Oct 30EarningsEarnings release — EPS $0.61 vs $0.57 est. (+7.0%); revenue $1.21B (+22% y/y) 14.6%
- Oct 30ReportQuarterly report, Q3 2025 — revenue $1.21B (+22% y/y), net income $283.8M, EPS $0.70
- Oct 278-K8-K · Dexcom Appoints Euan Ashley to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $12.3M in 25 sales and bought nothing on the open market; 47 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Oct 15, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffSold · $145K · 1,700 sh · 10b5-1 |
| Sep 28, 2026Form 4 | Stern SadieEVP Chief People & Culture OffSold · $221K · 2,565 sh · 10b5-1 |
| Sep 15, 2026Form 4 | AUGUSTINOS NICHOLASDirectorSold · $550K · 6,539 sh · 10b5-1 |
| Sep 15, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffSold · $143K · 1,700 sh · 10b5-1 |
| Sep 14, 2026Form 4 | AUGUSTINOS NICHOLASDirectorSold · $130K · 1,550 sh · 10b5-1 |
| Sep 10, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerSold · $303K · 3,638 sh · 10b5-1 |
| Aug 27, 2026Form 4 | Stern SadieEVP Chief People & Culture OffSold · $227K · 2,565 sh · 10b5-1 |
| Aug 20, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorSold · $2.4M · 26,756 sh · 10b5-1 |
| Aug 14, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffSold · $156K · 1,700 sh · 10b5-1 |
| Aug 12, 2026Form 4 | Heller Bridgette PDirectorSold · $89K · 1,012 sh · 10b5-1 |
| Aug 3, 2026Form 4 | FOLETTA MARK GDirectorSold · $171K · 2,000 sh · 10b5-1 |
| Jul 31, 2026Form 4 | FOLETTA MARK GDirectorSold · $160K · 2,000 sh · 10b5-1 |
| Jul 20, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorSold · $2.0M · 26,756 sh · 10b5-1 |
| Jul 15, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffSold · $127K · 1,700 sh · 10b5-1 |
| Jul 6, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorSold · $1.9M · 26,756 sh · 10b5-1 |
| Jun 15, 2026Form 4 | FOLETTA MARK GDirectorSold · $297K · 4,000 sh · 10b5-1 |
| Jun 15, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffSold · $128K · 1,700 sh · 10b5-1 |
| Jun 4, 2026Form 4 | Coleman JonEVP, Chief Commercial OfficerSold · $364K · 4,911 sh · 10b5-1 |
| Jun 3, 2026Form 4 | Coleman JonEVP, Chief Commercial OfficerSold · $359K · 4,912 sh · 10b5-1 |
| May 21, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorSold · $1.9M · 26,759 sh · 10b5-1 |
| May 15, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerSold · $102K · 1,700 sh · 10b5-1 |
| May 12, 2026Form 4 | Heller Bridgette PDirectorSold · $61K · 1,012 sh · 10b5-1 |
| Apr 15, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerSold · $107K · 1,700 sh · 10b5-1 |
| Mar 16, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerSold · $110K · 1,700 sh · 10b5-1 |
| Feb 12, 2026Form 4 | Heller Bridgette PDirectorSold · $69K · 1,012 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 47 transactions
| Date | Insider |
|---|---|
| Sep 10, 2026Form 4 | Boehnlein Glenn SDirectorAward · $0 · 5,841 sh |
| Aug 22, 2026Form 4 | Stern SadieEVP Chief People & Culture OffTax withholding · $134K · 1,451 sh |
| Aug 22, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffTax withholding · $134K · 1,451 sh |
| Aug 22, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerTax withholding · $134K · 1,451 sh |
| Aug 22, 2026Form 4 | Leach Jacob StevenPresident, CEO, and Director · DirectorTax withholding · $134K · 1,451 sh |
| Aug 12, 2026Form 4 | AUGUSTINOS NICHOLASDirectorGift · $0 · 1,075 sh |
| May 28, 2026Form 4 | FOLETTA MARK GDirectorAward · $0 · 6,331 sh |
| May 28, 2026Form 4 | GALA RENEE DDirectorAward · $0 · 5,605 sh |
| May 28, 2026Form 4 | Collins Richard AlexanderDirectorAward · $0 · 5,605 sh |
| May 28, 2026Form 4 | Driscoll RimmaDirectorAward · $0 · 5,605 sh |
| May 28, 2026Form 4 | Heller Bridgette PDirectorAward · $0 · 5,575 sh |
| May 28, 2026Form 4 | AUGUSTINOS NICHOLASDirectorAward · $0 · 5,575 sh |
| May 28, 2026Form 4 | Malady KyleDirectorAward · $0 · 5,575 sh |
| May 28, 2026Form 4 | Ashley Euan A.DirectorAward · $0 · 5,565 sh |
| May 28, 2026Form 4 | ALTMAN STEVEN RDirectorAward · $0 · 5,565 sh |
| May 28, 2026Form 4 | Osterloh Albert Frederick IVDirectorAward · $0 · 1,630 sh |
| May 22, 2026Form 4 | Coleman JonEVP, Chief Commercial OfficerTax withholding · $529K · 7,362 sh |
| May 22, 2026Form 4 | Stern SadieEVP Chief People & Culture OffTax withholding · $104K · 1,451 sh |
| May 22, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerTax withholding · $104K · 1,451 sh |
| May 22, 2026Form 4 | Brown Michael JonEVP Chief Legal Compliance OffTax withholding · $104K · 1,451 sh |
| May 22, 2026Form 4 | Leach Jacob StevenPresident, CEO, and Director · DirectorTax withholding · $104K · 1,451 sh |
| May 8, 2026Form 4 | FOLETTA MARK GDirectorGift · $0 · 11,462 sh |
| May 8, 2026Form 4 | Collins Richard AlexanderDirectorGift · $0 · 10,148 sh |
| May 8, 2026Form 4 | AUGUSTINOS NICHOLASDirectorGift · $0 · 10,092 sh |
| May 8, 2026Form 4 | ALTMAN STEVEN RDirectorGift · $0 · 10,074 sh |
| Mar 8, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorTax withholding · $2.2M · 32,498 sh |
| Mar 8, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerTax withholding · $1.6M · 23,325 sh |
| Mar 8, 2026Form 4 | Leach Jacob StevenPresident, CEO, and Director · DirectorTax withholding · $1.3M · 19,757 sh |
| Mar 8, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerTax withholding · $1.3M · 18,950 sh |
| Mar 8, 2026Form 4 | Stern SadieEVP, Chief HR OfficerTax withholding · $1.2M · 17,199 sh |
| Mar 8, 2026Form 4 | Leach Jacob StevenPresident, CEO, and Director · DirectorAward · $0 · 104,516 sh |
| Mar 8, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerAward · $0 · 48,774 sh |
| Mar 8, 2026Form 4 | Coleman JonEVP, Chief Commercial OfficerAward · $0 · 43,897 sh |
| Mar 8, 2026Form 4 | Stern SadieEVP, Chief HR OfficerAward · $0 · 39,019 sh |
| Mar 8, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerAward · $0 · 39,019 sh |
| Mar 8, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorAward · $0 · 32,749 sh |
| Feb 26, 2026Form 4 | Osterloh Albert Frederick IVDirectorAward · $0 · 7,061 sh |
| Jan 29, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorTax withholding · $2.5M · 34,257 sh |
| Jan 29, 2026Form 4 | Leach Jacob StevenPresident, CEO, and Director · DirectorTax withholding · $224K · 3,058 sh |
| Jan 29, 2026Form 4 | Stern SadieEVP, Chief HR OfficerTax withholding · $195K · 2,656 sh |
| Jan 29, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerTax withholding · $195K · 2,653 sh |
| Jan 29, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerTax withholding · $195K · 2,652 sh |
| Jan 29, 2026Form 4 | SAYER KEVIN RExecutive Chair · DirectorAward · $0 · 71,218 sh |
| Jan 29, 2026Form 4 | Leach Jacob StevenPresident, CEO, and Director · DirectorAward · $0 · 8,310 sh |
| Jan 29, 2026Form 4 | Brown Michael JonEVP, Chief Legal OfficerAward · $0 · 7,123 sh |
| Jan 29, 2026Form 4 | Sylvain Jereme MEVP, Chief Financal OfficerAward · $0 · 7,123 sh |
| Jan 29, 2026Form 4 | Stern SadieEVP, Chief HR OfficerAward · $0 · 7,123 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 16 filings
| Filed | What it is |
|---|---|
| Sep 14, 20268-K | Dexcom Promotes Jereme Sylvain to Chief Operating OfficerDirectors or officers; compensation; Regulation FD disclosure |
| Sep 10, 20268-K | Dexcom Appoints Glenn Boehnlein to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure |
| Jul 30, 202610-Q | Quarterly report, Q2 2026 — revenue $1.31B (+13% y/y), net income $249.1M, EPS $0.64 |
| Jul 30, 20268-K | Earnings release — EPS $0.70 vs $0.61 est. (+14.8%); revenue $1.31B (+13% y/y) 12.0% |
| May 28, 20268-K | Shareholder vote results |
| May 15, 20268-K | Regulation FD disclosure; Other events |
| Apr 30, 202610-Q | Quarterly report, Q1 2026 — revenue $1.19B (+15% y/y), net income $199.5M, EPS $0.51 |
| Apr 30, 20268-K | Earnings release — EPS $0.56 vs $0.47 est. (+19.1%); revenue $1.19B (+15% y/y) 3.0% |
| Apr 15, 2026ARS | Annual report to shareholders |
| Apr 15, 2026DEFA14A | Additional proxy materials |
| Apr 15, 2026DEF 14A | Proxy statement |
| Mar 2, 20268-K | Directors or officers; compensation |
| Feb 26, 20268-K | Dexcom Appoints Rick Osterloh to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure |
| Feb 12, 202610-K | Annual report, FY2025 — revenue $4.66B (+16% y/y), net income $836.3M, EPS $2.09 |
| Feb 12, 20268-K | Earnings release — EPS $0.68 vs $0.65 est. (+4.6%); revenue $1.26B (+13% y/y) 7.6% |
| Jan 12, 20268-K | Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 OutlookResults of operations |
2025 · 23 filings
| Filed | What it is |
|---|---|
| Dec 22, 20258-K | Directors or officers; compensation |
| Oct 30, 202510-Q | Quarterly report, Q3 2025 — revenue $1.21B (+22% y/y), net income $283.8M, EPS $0.70 |
| Oct 30, 20258-K | Earnings release — EPS $0.61 vs $0.57 est. (+7.0%); revenue $1.21B (+22% y/y) 14.6% |
| Oct 27, 20258-K | Dexcom Appoints Euan Ashley to Board of DirectorsDirectors or officers; compensation; Regulation FD disclosure |
| Sep 16, 20258-K | Directors or officers; compensation |
| Jul 30, 202510-Q | Quarterly report, Q2 2025 — revenue $1.16B (+15% y/y), net income $179.8M, EPS $0.45 |
| Jul 30, 20258-K | Earnings release — EPS $0.48 vs $0.45 est. (+6.7%); revenue $1.16B (+15% y/y) 9.3% |
| May 13, 20258-K | Directors or officers; compensation |
| May 9, 20258-K/A | Directors or officers; compensation |
| May 9, 20258-K | Directors or officers; compensation; Shareholder vote results |
| May 2, 2025DEFA14A | Additional proxy materials |
| May 2, 20258-K | Directors or officers; compensation |
| May 1, 202510-Q | Quarterly report, Q1 2025 — revenue $1.04B (+12% y/y), net income $105.4M, EPS $0.27 |
| May 1, 20258-K | Earnings release — EPS $0.32 vs $0.33 est. (−3.0%); revenue $1.04B (+12% y/y) 16.2% |
| Mar 27, 2025ARS | Annual report to shareholders |
| Mar 27, 2025DEFA14A | Additional proxy materials |
| Mar 27, 2025DEF 14A | Proxy statement |
| Mar 25, 20258-K | Change of auditor |
| Mar 10, 20258-K | Directors or officers; compensation; Regulation FD disclosure |
| Mar 7, 20258-K | Regulation FD disclosure; Other events |
| Feb 18, 202510-K | Annual report, FY2024 — revenue $4.03B (+11% y/y), net income $576.2M, EPS $1.42 |
| Feb 13, 20258-K | Earnings release — EPS $0.45 vs $0.50 est. (−10.0%); revenue $1.11B (+8% y/y) 5.9% |
| Jan 13, 20258-K | Results of operations |
2024 · 14 filings
| Filed | What it is |
|---|---|
| Dec 23, 20248-K | Material definitive agreement |
| Oct 24, 202410-Q | Quarterly report, Q3 2024 — revenue $994.2M (+2% y/y), net income $134.6M, EPS $0.34 |
| Oct 24, 20248-K | Earnings release — EPS $0.45 vs $0.43 est. (+4.7%); revenue $994.2M (+2% y/y) 1.9% |
| Jul 25, 202410-Q | Quarterly report, Q2 2024 — revenue $1.00B (+15% y/y), net income $143.5M, EPS $0.35 |
| Jul 25, 20248-K | Earnings release — EPS $0.43 vs $0.39 est. (+10.3%); revenue $1.00B (+15% y/y) 40.7% |
| May 24, 20248-K | Shareholder vote results |
| Apr 25, 202410-Q | Quarterly report, Q1 2024 — revenue $921.0M (+24% y/y), net income $146.4M, EPS $0.36 |
| Apr 25, 20248-K | Earnings release — EPS $0.32 vs $0.27 est. (+18.5%); revenue $921.0M (+24% y/y) 9.9% |
| Apr 22, 2024ARS | Annual report to shareholders |
| Apr 22, 2024DEF 14A | Proxy statement |
| Feb 15, 20248-K | Material definitive agreement; Termination of a material agreement; Unregistered sale of equity |
| Feb 8, 202410-K | Annual report, FY2023 — revenue $3.62B (+24% y/y), net income $541.5M, EPS $1.30 |
| Feb 8, 20248-K | Earnings release — EPS $0.50 vs $0.43 est. (+16.3%); revenue $1.03B (+27% y/y) 5.2% |
| Jan 8, 20248-K | Results of operations |
2023 · 20 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 26, 202310-Q | Quarterly report, Q3 2023 — revenue $975.0M (+27% y/y), net income $120.7M, EPS $0.29 |
| Jul 27, 202310-Q | Quarterly report, Q2 2023 — revenue $871.3M (+25% y/y), net income $115.9M, EPS $0.28 |
| Apr 27, 202310-Q | Quarterly report, Q1 2023 — revenue $741.5M (+18% y/y), net income $48.6M, EPS $0.12 |
| Apr 6, 2023ARS | Annual report to shareholders |
| Apr 6, 2023DEFA14A | Additional proxy materials |
| Apr 6, 2023DEF 14A | Proxy statement |
| Feb 9, 202310-K | Annual report, FY2022 — revenue $2.91B (+19% y/y), net income $341.2M, EPS $0.82 |
13 current reports (8-K) not listed; the year is on EDGAR.
2022 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202210-Q | Quarterly report, Q3 2022 — revenue $769.6M (+18% y/y), net income $101.2M, EPS $0.24 |
| Jul 28, 202210-Q | Quarterly report, Q2 2022 — revenue $696.2M (+17% y/y), net income $50.9M, EPS $0.12 |
| Apr 28, 202210-Q | Quarterly report, Q1 2022 — revenue $628.8M (+25% y/y), net income $97.3M, EPS $0.23 |
| Apr 8, 2022DEFA14A | Additional proxy materials |
| Apr 8, 2022DEF 14A | Proxy statement |
| Mar 25, 2022PRE 14A | Preliminary proxy statement |
| Feb 14, 202210-K | Annual report, FY2021 — revenue $2.45B (+27% y/y), net income $216.9M, EPS $0.53 |
11 current reports (8-K) not listed; the year is on EDGAR.
2021 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202110-Q | Quarterly report, Q3 2021 — revenue $650.2M (+30% y/y), net income $87.3M, EPS $0.21 |
| Jul 29, 202110-Q | Quarterly report, Q2 2021 — revenue $595.1M (+32% y/y), net income $78.4M, EPS $0.19 |
| Apr 29, 202110-Q | Quarterly report, Q1 2021 — revenue $505.0M (+25% y/y), net income $56.5M, EPS $0.56 |
| Apr 9, 2021DEFA14A | Additional proxy materials |
| Apr 9, 2021DEF 14A | Proxy statement |
| Mar 26, 2021PRE 14A | Preliminary proxy statement |
| Feb 11, 202110-K | Annual report, FY2020 — revenue $1.93B (+31% y/y), net income $549.7M, EPS $1.33 |
14 current reports (8-K) not listed; the year is on EDGAR.
2020 · 23 filings — 16 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202010-Q | Quarterly report, Q3 2020 — revenue $500.9M (+26% y/y), net income $72.2M, EPS $0.73 |
| Jul 28, 202010-Q | Quarterly report, Q2 2020 — revenue $451.8M (+34% y/y), net income $46.3M, EPS $0.48 |
| May 8, 2020DEFA14A | Additional proxy materials |
| Apr 28, 202010-Q | Quarterly report, Q1 2020 — revenue $405.1M (+44% y/y), net income $19.9M, EPS $0.21 |
| Apr 10, 2020DEFA14A | Additional proxy materials |
| Apr 10, 2020DEF 14A | Proxy statement |
| Feb 13, 202010-K | Annual report, FY2019 — revenue $1.48B (+43% y/y), net income $101.1M, EPS $1.10 |
16 current reports (8-K) not listed; the year is on EDGAR.
2019 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201910-Q | Quarterly report, Q3 2019 — revenue $396.3M (+49% y/y), net income $45.8M, EPS $0.50 |
| Jul 31, 201910-Q | Quarterly report, Q2 2019 — revenue $336.4M (+39% y/y), net income −$10.5M, EPS −$0.12 |
| May 1, 201910-Q | Quarterly report, Q1 2019 — revenue $280.5M (+52% y/y), net income −$26.9M, EPS −$0.30 |
| Apr 19, 2019DEFA14A | Additional proxy materials |
| Apr 19, 2019DEF 14A | Proxy statement |
| Feb 21, 201910-K | Annual report, FY2018 — revenue $1.03B (+44% y/y), net income −$127.1M, EPS −$1.44 |
8 current reports (8-K) not listed; the year is on EDGAR.
2018 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201810-Q | Quarterly report, Q3 2018 — revenue $266.7M (+44% y/y), net income $46.6M, EPS $0.52 |
| Aug 1, 201810-Q | Quarterly report, Q2 2018 — revenue $242.5M (+42% y/y), net income $30.2M, EPS $0.34 |
| May 2, 201810-Q | Quarterly report, Q1 2018 — revenue $184.4M (+30% y/y), net income −$24.2M, EPS −$0.28 |
| Apr 20, 2018DEFA14A | Additional proxy materials |
| Apr 20, 2018DEF 14A | Proxy statement |
| Feb 27, 201810-K | Annual report, FY2017 — revenue $718.5M (+25% y/y), net income −$50.2M, EPS −$0.58 |
14 current reports (8-K) not listed; the year is on EDGAR.
2017 · 21 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201710-Q | Quarterly report, Q3 2017 — revenue $184.6M (+24% y/y), net income −$2.0M, EPS −$0.02 |
| Aug 1, 201710-Q | Quarterly report, Q2 2017 — revenue $170.6M (+24% y/y), net income $2.9M, EPS $0.03 |
| May 2, 201710-Q | Quarterly report, Q1 2017 — revenue $142.3M (+22% y/y), net income −$41.7M, EPS −$0.49 |
| Apr 20, 2017DEFA14A | Additional proxy materials |
| Apr 20, 2017DEF 14A | Proxy statement |
| Mar 22, 2017PRE 14A | Preliminary proxy statement |
| Feb 28, 201710-K | Annual report, FY2016 — revenue $573.3M (+43% y/y), net income −$65.6M |
14 current reports (8-K) not listed; the year is on EDGAR.
2016 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2014 · 18 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2013 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2012 · 15 filings — 7 × 8-K, 3 × 10-Q, 2 × 10-K/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 19 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 28 filings — 22 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2009 · 20 filings — 13 × 8-K, 3 × 10-Q, 2 × 8-K/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2008 · 24 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2007 · 25 filings — 20 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2006 · 18 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2005 · 12 filings — 9 × 8-K, 3 × 10-Q
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 90 filings — 59 × 4, 25 × 144, 2 × 3 and 3 other forms
| Filed | What it is |
|---|---|
| Oct 19, 20264 | Insider transaction (Form 4) |
| Oct 15, 2026144 | Notice of proposed sale (Form 144) |
| Sep 30, 20264 | Insider transaction (Form 4) |
| Sep 28, 2026144 | Notice of proposed sale (Form 144) |
| Sep 16, 20264 | Insider transaction (Form 4) |
| Sep 16, 20264 | Insider transaction (Form 4) |
| Sep 15, 2026144 | Notice of proposed sale (Form 144) |
| Sep 15, 2026144 | Notice of proposed sale (Form 144) |
| Sep 14, 20264 | Insider transaction (Form 4) |
| Sep 14, 2026144 | Notice of proposed sale (Form 144) |
| Sep 10, 20264 | Insider transaction (Form 4) |
| Sep 10, 20263 | Initial insider holdings (Form 3) |
| Sep 10, 2026144 | Notice of proposed sale (Form 144) |
| Aug 28, 20264 | Insider transaction (Form 4) |
| Aug 27, 2026144 | Notice of proposed sale (Form 144) |
| Aug 25, 20264 | Insider transaction (Form 4) |
| Aug 25, 20264 | Insider transaction (Form 4) |
| Aug 25, 20264 | Insider transaction (Form 4) |
| Aug 25, 20264 | Insider transaction (Form 4) |
| Aug 24, 20264 | Insider transaction (Form 4) |
| Aug 20, 2026144 | Notice of proposed sale (Form 144) |
| Aug 17, 20264 | Insider transaction (Form 4) |
| Aug 14, 2026144 | Notice of proposed sale (Form 144) |
| Aug 13, 20264 | Insider transaction (Form 4) |
| Aug 13, 20264 | Insider transaction (Form 4) |
The newest 25 of 90 shown; the full year is on EDGAR.
2025 · 75 filings — 47 × 4, 19 × 144, 3 × 3 and 5 other forms
| Filed | What it is |
|---|---|
| Nov 17, 20254 | Insider transaction (Form 4) |
| Nov 14, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 20254 | Insider transaction (Form 4) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 10, 20254 | Insider transaction (Form 4) |
| Nov 10, 20254 | Insider transaction (Form 4) |
| Nov 10, 2025144 | Notice of proposed sale (Form 144) |
| Oct 30, 2025SCHEDULE 13G/A | Other filings |
| Oct 28, 20254 | Insider transaction (Form 4) |
| Oct 28, 20253 | Initial insider holdings (Form 3) |
| Sep 9, 20254 | Insider transaction (Form 4) |
| Sep 8, 20254 | Insider transaction (Form 4) |
| Sep 5, 2025144 | Notice of proposed sale (Form 144) |
| Sep 4, 2025144 | Notice of proposed sale (Form 144) |
| Sep 4, 20254 | Insider transaction (Form 4) |
| Sep 2, 2025144 | Notice of proposed sale (Form 144) |
| Aug 18, 20254 | Insider transaction (Form 4) |
| Aug 18, 20254 | Insider transaction (Form 4) |
| Aug 15, 2025144 | Notice of proposed sale (Form 144) |
| Aug 15, 2025144 | Notice of proposed sale (Form 144) |
| Jul 29, 20254 | Insider transaction (Form 4) |
| Jul 28, 2025144 | Notice of proposed sale (Form 144) |
| Jul 17, 20254 | Insider transaction (Form 4) |
| Jul 17, 20254 | Insider transaction (Form 4) |
| Jul 15, 2025144 | Notice of proposed sale (Form 144) |
The newest 25 of 75 shown; the full year is on EDGAR.
2024 · 97 filings — 62 × 4, 31 × 144, 3 × SC 13G/A and 1 other form
| Filed | What it is |
|---|---|
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 17, 20244 | Insider transaction (Form 4) |
| Dec 16, 2024144 | Notice of proposed sale (Form 144) |
| Dec 6, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 18, 20244 | Insider transaction (Form 4) |
| Nov 15, 2024144 | Notice of proposed sale (Form 144) |
| Sep 17, 20244 | Insider transaction (Form 4) |
| Sep 16, 2024144 | Notice of proposed sale (Form 144) |
| Sep 11, 20244 | Insider transaction (Form 4) |
| Sep 11, 20244 | Insider transaction (Form 4) |
| Sep 11, 20244 | Insider transaction (Form 4) |
| Sep 3, 20244 | Insider transaction (Form 4) |
| Aug 30, 2024144 | Notice of proposed sale (Form 144) |
| Aug 1, 20244 | Insider transaction (Form 4) |
| Jul 31, 2024144 | Notice of proposed sale (Form 144) |
| Jun 28, 20244 | Insider transaction (Form 4) |
| Jun 28, 2024144 | Notice of proposed sale (Form 144) |
| Jun 20, 20244 | Insider transaction (Form 4) |
| Jun 18, 20244 | Insider transaction (Form 4) |
| Jun 18, 2024144 | Notice of proposed sale (Form 144) |
| Jun 17, 2024144 | Notice of proposed sale (Form 144) |
| Jun 14, 2024144 | Notice of proposed sale (Form 144) |
The newest 25 of 97 shown; the full year is on EDGAR.
2023 · 136 filings — 96 × 4, 33 × 144, 4 × SC 13G/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2022 · 65 filings — 53 × 4, 3 × 3, 3 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2021 · 136 filings — 113 × 4, 11 × S-8 POS, 5 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2020 · 144 filings — 128 × 4, 7 × SC 13G/A, 6 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2019 · 120 filings — 102 × 4, 7 × SC 13G/A, 5 × 5 and 5 other forms
Counted, not listed; the year is on EDGAR.
2018 · 121 filings — 102 × 4, 9 × SC 13G/A, 7 × 4/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2017 · 112 filings — 94 × 4, 7 × SC 13G/A, 5 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2016 · 167 filings — 151 × 4, 5 × SC 13G/A, 3 × CT ORDER and 6 other forms
Counted, not listed; the year is on EDGAR.
2015 · 196 filings — 183 × 4, 4 × SC 13G/A, 2 × S-8 and 5 other forms
Counted, not listed; the year is on EDGAR.
2014 · 183 filings — 172 × 4, 3 × SC 13G/A, 2 × CT ORDER and 5 other forms
Counted, not listed; the year is on EDGAR.
2013 · 69 filings — 62 × 4, 3 × SC 13G/A, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 55 filings — 46 × 4, 2 × S-3ASR, 2 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2011 · 28 filings — 18 × 4, 2 × 3, 2 × CT ORDER and 5 other forms
Counted, not listed; the year is on EDGAR.
2010 · 36 filings — 25 × 4, 4 × SC 13G/A, 2 × 424B2 and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 45 filings — 20 × 4, 5 × SC 13G/A, 4 × 3 and 10 other forms
Counted, not listed; the year is on EDGAR.
2008 · 62 filings — 43 × 4, 7 × 3, 3 × SC 13G/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2007 · 57 filings — 36 × 4, 4 × SC 13G/A, 3 × 3 and 9 other forms
Counted, not listed; the year is on EDGAR.
2006 · 98 filings — 80 × 4, 4 × SC 13G, 3 × S-1/A and 9 other forms
Counted, not listed; the year is on EDGAR.
2005 · 92 filings — 54 × 4, 21 × 3, 7 × S-1/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2002 · 1 filing — 1 × REGDEX
Counted, not listed; the year is on EDGAR.
About this data#
DexCom Inc. (DXCM) has 2,601 filings on EDGAR going back to 2002: 23 annual reports, 66 quarterly reports and 279 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 12, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 14, 2026, furnished a press release headed “Dexcom Promotes Jereme Sylvain to Chief Operating Officer”. Over the last 13 months insiders sold $12.3M in 25 sales and bought nothing on the open market; 47 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been DexCom Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read DXCM's latest 10-K?
- DXCM's latest annual report, a 10-K, was filed on Feb 12, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did DXCM last file an 8-K?
- On Sep 14, 2026 it furnished a press release headed “Dexcom Promotes Jereme Sylvain to Chief Operating Officer”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 30, 2026.
- Are DXCM insiders buying or selling?
- Over the last 13 months insiders sold $12.3M in 25 sales and bought nothing on the open market; 47 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Brown Michael Jon (EVP Chief Legal Compliance Off) sold 1,700 shares on Oct 15, 2026 for $145K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has DXCM made?
- 2,601 filings are on EDGAR under the registrant records that have been DexCom Inc., going back to 2002; 1,945 of them are insider ownership forms (Forms 3, 4, 5 and 144).